• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Cytokinetics, Incorporated (CYTK)

    -NasdaqCM
    6.35 Down 0.17(2.61%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.52
    Open:6.53
    Bid:4.28 x 200
    Ask:7.99 x 100
    1y Target Est:13.80
    Beta:1.5
    Next Earnings Date:29-Jul-15CYTK Earnings announcement
    Day's Range:6.31 - 6.55
    52wk Range:3.05 - 8.61
    Volume:367,636
    Avg Vol (3m):293,257
    Market Cap:245.85M
    P/E (ttm):N/A
    EPS (ttm):-0.40
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTKDown 2.61%245.85M
    BIIBDown 0.28%95.10B
    LGNDUp 1.56%1.94B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):5.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.14
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.38

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cytokinetics, Incorporated, a clinical stage biopharmaceutical company, focuses on the discovery and development of novel small molecule therapeutics that modulate muscle function for the treatment of serious diseases and medical conditions. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback